AlphAIAlphAI — Financial news for AI agents
financialcontent.comSEP 92 min read$CAL

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.

Original reporting
financialcontent.com
Published Sep 9, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 5:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Caleres (CAL) Stock Trades Up, Here Is Why — source image
Source · financialcontent.com
Decision brief

The 30-second read

$CALBullishHigh
01

Why it matters

Earnings beat and guidance raise suggest stronger near‑term earnings momentum.

02

Market read

Potential upside of 5‑10% over the next few weeks if guidance holds.

03

Timing

morning session

Relevance 8/10Novelty 8/10Timing: morning session
Company-level read

Ticker impact

$CALBullishHigh confidence
Context

Caleres reported Q2 earnings beat and raised the low end of its FY adjusted EPS guidance, driving a 9.7% price jump.

Expected impact

Potential upside of 5‑10% over the next few weeks if guidance holds.

Evidence & confidence

The surprise earnings beat and upward guidance are fresh, material information for a volatile stock.

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 10
$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

fool.com6 min
SEP 9
$CALMedAI 8/10

Caleres Q2 Earnings Call Highlights

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.

yahoo.com2 min
SEP 9
$CALHighAI 8/10

Caleres (NYSE:CAL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.2%

Caleres (NYSE: CAL) reported Q2 CY2026 sales of $695.5M, up 5.6% YoY but below estimates. Non-GAAP EPS of $0.47 beat forecasts by 27%. Revenue growth has averaged 2.4% annually over five years, with flat performance in the last two years. Operating margin improved to 11.2%, up 8.6 percentage points YoY. EPS declined 12.6% annually over five years despite revenue growth. Stock rose 5.2% post-results.

financialcontent.com2 min
SEP 9
$CALHighAI 8/10

Caleres Reports Second Quarter 2026 Results

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6% YoY. Brand Portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. GAAP EPS was $1.71, exceeding guidance. The company expects low-single-digit sales growth in Q3 and FY 2026, with improved gross margins.

aol.com2 min